Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, calls on the MedTech sector to engage with the latest step in delivering Value Based Procurement.
The UK Health Department is taking a significant step forward in revolutionising healthcare procurement by inviting stakeholders to help shape a new evaluation methodology for Value-Based Procurement (VBP) of medical technology. The initiative aims to ensure that procurement decisions are driven by value, patient outcomes, and cost-effectiveness, rather than just the initial purchase price.
A Collaborative Effort
The NHS is calling on healthcare professionals, suppliers, and other stakeholders to contribute their insights and expertise to develop a robust and comprehensive evaluation framework. This collaborative approach is designed to capture a wide range of perspectives, ensuring that the new methodology is both practical and impactful.
Enhancing Patient Outcomes
By focusing on value-based procurement, the NHS aims to enhance patient outcomes and deliver better healthcare services. This new approach will prioritise medical technologies that offer the greatest benefits to patients, improving the overall quality of care. It also aligns with the broader goals of the NHS to provide sustainable and efficient healthcare solutions.
Driving Innovation
The initiative is expected to drive innovation within the medical technology sector. By emphasising value and outcomes, suppliers will be encouraged to develop and offer products that deliver superior performance and long-term benefits. This shift towards value-based procurement is anticipated to foster a more competitive and dynamic market, ultimately benefiting patients and healthcare providers alike.
Get Involved
Stakeholders are encouraged to participate in this exciting initiative by providing feedback and suggestions. The NHS is committed to creating a transparent and inclusive process, ensuring that the new evaluation methodology reflects the needs and priorities of all involved parties.
After several years’ work encouraging the MedTech Directorate of DHSC to adopt and promote Value Based Procurement, it’s great to see it finally taking shape and that real world tests are being lined up. Adoption of VBP will deliver better patient experiences and outcomes, more support for clinicians, and massive reductions in NHS costs. This move is very much to be welcomed.
For more information and to get involved, visit the Health Care Supply Association website.
The Author used AI in preparing this article. Comments upon or questions about this article can be addressed to chris.whitehouse@whitehousecomms.com.
